Larry Herrera - Concepedia

Author

Larry Herrera

The University of Texas Southwestern Medical Center

Also Known As

L Herrera, L. Barrera Herrera, L. Herrera, Larry Herrera

Publications

536

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Temple University Children's Medical Center Scott & White Memorial Hospital

About

Larry Herrera is an author at The University of Texas Southwestern Medical Center specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	148
2	Immunology	4	4	148
3	Cell Biology	2	2	111
4	Health Sciences	1	1	22
5	Cellular Therapies	1	1	48

Larry Herrera

Publications

424

Citations

H-Index

Page 1

	Year	Citations
BCR/ABL Inhibits Mismatch Repair to Protect from Apoptosis and Induce Point Mutations Tomasz Stokłosa, Tomasz Popławski, Mateusz Koptyra, Cancer Research	2008	97
A Phase 1 Study of Combotox in Pediatric Patients With Refractory B-lineage Acute Lymphoblastic Leukemia Larry Herrera, Bruce Bostrom, Lisa Gore, Journal of Pediatric Hematology/Oncology	2009	90
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer Victor M. Aquino, Larry Herrera, Eric Sandler, Cancer	2000	77
Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro Larry Herrera, V Pellegrini Leukemia ImmunologyHematologyImmunologic MechanismAdult T-cell Leukemia-lymphomaMedicine	2000	63
Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins Larry Herrera, Stephen R. Yarbrough, Victor Gheţie, Leukemia Cell TherapyAutoimmune DiseaseAnti-cd22 ImmunotoxinsImmunologyAutoimmunity	2003	48
Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines C. Stanciu-Herrera, Charles H. Morgan, Larry Herrera Leukemia Research Hematological MalignancyLymphoid NeoplasiaAnti-cd22 Monoclonal AntibodiesMedicineMixed-phenotype Acute Leukemia	2007	22
Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia Larry Herrera, C. Stanciu-Herrera, Charles H. Morgan, Leukemia & lymphoma/Leukemia and lymphoma ImmunotoxicologyImmunologyEffective CombinationsPathologyCell Death	2006	15
Fractionated Cyclophosphamide and Etoposide for Children With Advanced or Refractory Solid Tumors: A Phase II Window Study Elpis Mantadakis, Larry Herrera, Patrick J. Leavey, Journal of Clinical Oncology	2000	12

Page 1